• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIRGAS THERAPEUTICS LLC ISPAN PERFLUOROPROPANE (C3F8) GAS; INTRAOCULAR GAS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIRGAS THERAPEUTICS LLC ISPAN PERFLUOROPROPANE (C3F8) GAS; INTRAOCULAR GAS Back to Search Results
Catalog Number 8065797102
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cataract (1766); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/10/2023
Event Type  Injury  
Event Description
A clinical study reported that 60 years old female patient underwent posterior vitrectomy surgery, surgeon found that the ophthalmic gas content was less than half during the surgery.Again, surgery was conducted for ophthalmic gas installation in the eye.After the surgery, surgeon observed that there was anterior chamber flickers in the eye, blood cells attached on cornea, cells, high crystal density noted in patient eye.Symptoms were treated with medications.Symptoms are improving.
 
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Additional information is provided in sections h.6 and h.10.A check of the batch production record showed no unusual manufacturing issues.A check of the complaint records showed no other complaints against this lot.A check of confirmed complaints for c3f8 (pfp) utilization resulting in low gas content in the eye and/or anterior chamber flicker showed no other complaints since the beginning of 2016.There was no sample returned for evaluation.An analysis of the retain sample this lot showed that the product was pfp and met ail release criteria.Nothing was found that would account for the reported event.The root cause of the reported event cannot be determined.Manufacturer will continue to monitor data for evidence of adverse trending and take further action, as appropriate.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISPAN PERFLUOROPROPANE (C3F8) GAS
Type of Device
INTRAOCULAR GAS
Manufacturer (Section D)
AIRGAS THERAPEUTICS LLC
6141 easton road
p.o. box 310
plumsteadville PA 18949
Manufacturer (Section G)
AIRGAS THERAPEUTICS LLC
6141 easton road
p.o. box 310
plumsteadville PA 18949
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17624222
MDR Text Key321959497
Report Number2518435-2023-00028
Device Sequence Number1
Product Code LPO
UDI-Device Identifier00380657971022
UDI-Public00380657971022
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P900066
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number8065797102
Device Lot Number216804
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/10/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/05/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age60 YR
Patient SexFemale
-
-